window.globalProvideData('caption', '{"data":"WEBVTT%0D%0AKind:%20captions%0D%0ASource:%20Articulate%20Closed%20Captions%20Editor%0D%0ASource%20Version:%206.20.16814.0%0D%0A%0D%0A00:00:00.480%20--%3E%2000:00:05.844%0D%0AThe%20Biosafety%20Office%20will%20help%20determine%20which%20sections%20of%20the%20NIH%20Guidelines%20apply%20to%20your%20research.%0D%0A%0D%0A00:00:06.208%20--%3E%2000:00:10.912%0D%0A%20Sections%20III%20A%20through%20B%20of%20the%20NIH%20Guidelines%20are%20for%20%E2%80%9Cmajor%20actions,%E2%80%9D%20%0D%0A%0D%0A00:00:11.296%20--%3E%2000:00:14.816%0D%0Asuch%20as%20the%20deliberate%20transfer%20of%20a%20drug%20resistance%20trait%0D%0A%0D%0A%0D%0A00:00:15.200%20--%3E%2000:00:18.272%0D%0Aand%20for%20cloning%20of%20toxin%20molecules%20with%20an%20LD50%0D%0A%0D%0A00:00:18.304%20--%3E%2000:00:22.692%0D%0Aof%20less%20than%20100%20nanograms/kilogram%20of%20body%20weight,%20respectively.%20%0D%0A%0D%0A00:00:23.144%20--%3E%2000:00:27.056%0D%0ASection%20III%20C%20is%20for%20human%20gene%20transfer%20studies.%20%20%0D%0A%0D%0A00:00:27.296%20--%3E%2000:00:29.440%0D%0A%0D%0A%0D%0A00:00:29.856%20--%3E%2000:00:36.596%0D%0Are%20for%20experiments%20involving%20Risk%20Group%202%20or%20higher%20pathogens%20and%20Risk%20Group%201%20organisms,%20respectively.%20%E2%80%A8%0D%0A%0D%0A00:00:37.600%20--%3E%2000:00:45.912%0D%0AAlso%20noteworthy%20is%20that%20use%20of%20certain%20hosts%20and%20vectors%20falls%20under%20Section%20III%20F%20and%20is%20exempt%20from%20the%20NIH%20Guidelines.%0D%0A%0D%0A00:00:46.112%20--%3E%2000:00:48.960%0D%0A%0D%0A%0D%0A00:00:49.312%20--%3E%2000:00:55.264%0D%0A%0D%0A%0D%0A00:00:55.296%20--%3E%2000:00:59.648%0D%0A%0D%0A%0D%0A"}')